Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay

A nucleic acid sequence and target sequence technology, which is applied in the field of reducing the dependence on the sequence variation of the target nucleic acid in diagnostic hybridization assays, and can solve problems such as unsuitable primers

Inactive Publication Date: 2011-08-24
BIOMERIEUX SA
View PDF8 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] As mentioned in the literature above, one disadvantage of this method is that it is only specific for probes and not for primers
Furthermore, the method requires the use and design of two probes

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay
  • Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay
  • Method for lowering the dependency towards sequence variation of a nucleic acid target in a diagnostic hybridization assay

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Example 1: Amplification of HCV RNA using deletion p1 primers

[0093] Using two different p1 primers (HCV-E2 p1a or HCV-E2 p1d (Table 1)), in combination with the p2 primer, amplified in the presence of HCV-specific molecular beacons (HCV-E2 reference MB (Table 1)) Part of the E2 region of HCV. Primer HCV-E2 p1d is similar to primer p1a except for a deletion of one nucleotide at the position of a nucleotide variation that occurs between different HCV subtypes. This primer HCV-E2 p1d was named "deletion primer".

[0094] Use a dilution series of in vitro transcribed HCV RNA (5.10 5 to 50 copies) as input material for amplification. Amplification using standard EasyQ Basic Kit NASBA reagents (bioMérieux B.V., Boxtel, Netherlands) (40mM Tris-HCl pH 8.5, 12mM MgCl 2 , 80mM KCl, 15% v / vDMSO, 5mM DTT, 1mM each dNTP, 2mM ATP, 2mM CTP, 2mM UTP, 1.5mM GTP, 0.5mM ITP, 0.2μM each primer and 0.01μM molecular beacon probe) . The mixture was incubated at 65°C for 2 minutes to ...

Embodiment 2

[0096] Example 2: Amplification of HCV RNA using different deletion pl primers

[0097] Amplification of HCV was performed in the presence of HCV-specific molecular beacons (HCV-E2 reference MB (Table 1)) using different HCV-E2 p1 deletion primers in combination with the p2 primer HCV-E2 p2b (Table 1). In addition to HCV-E2-p1d, new deletion primers HCV-E2 p1e, HCV-E2 p1f and HCV-E2 p1g were also tested. HCV-E2 p1d includes one deletion, HCV-E2 p1e and p1f include two deletions, and HCV-E2 p1g includes three deletions, all at positions of nucleotide variations that occur between different HCV subtypes (Table 1 ). Use a dilution series of in vitro transcribed HCV RNA (5.10 5 to 50 copies) as input material for amplification. Amplification was performed as described in Example 1. The results are shown in Figure 2.

[0098] The results show that amplification is possible with p1 primers including up to three deletions, with equal or even better assay sensitivity compared to ...

Embodiment 3

[0099] Example 3: Amplification of HIV RNA using different deletion pl primers

[0100] Amplification was performed in the presence of HIV-specific molecular beacons (HIV WT MB (Me23), Table 1 ) using different HIV deletion p1 primers in combination with the p2 primer HIV-reference p2b (Table 1 ). The p1 primers used were HIV.55 and HIV.56 (Table 1) including one nucleotide deletion and HIV.57 (Table 1) including two deletions that occur between the nucleosides of the different HCV subtypes The location of the acid mutation. P1 primer HIV.27 without deletion was used as reference. HIV particles from cell culture, lysed with lysis buffer (NucliSens Extraction reagents, bioMérieux, Boxtel, Netherlands) were used as input material for amplification. Input amounts of 500, 50 and 5 International Units (IU) of this HIV subtype sample (WRS: Working Reference Standard) were used. Amplification was performed as described in Example 1, except that a lower KCl concentration (70 mM) wa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides primer or / and probe, this target sequence containing at least one variation, defined as either one non-conserved nucleotide, called genotype variation, or one nucleotide variation within one and the same genotype, wherein the primer or / and probe comprises a nucleic acid sequence that is complementary to said target sequence except for the at least complementary base of the variation(s), which is not present in the primer or / and probe. The present invention is especially useful in methods for diagnostic, preventive and therapeutic applications.

Description

field of invention [0001] The present invention relates to primers designed to overcome differences in amplification efficiency due to variability in primer binding, non-conserved nucleotides in target nucleic acid sequences, such as variation between different genotypes. By deleting the complementary base of a non-conserved nucleotide, the binding of a primer (called a deletion primer) will be the same for all targets (genotypes). The invention can be transferred to other technical levels, for example in quantitative assays as an internal control and / or for the detection of other nucleic acid sequences competing with the target, wherein between variants of the target nucleic acid, the pairing of the target, the internal control by said missing primer Amplification by and / or competing sequences is comparable. Background of the invention [0002] Advances in molecular biology have made it possible to achieve sensitive detection of nucleic acids through the use of amplificati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68
CPCC12Q2600/156C12Q1/6876
Inventor B·戴曼D·范斯特里普
Owner BIOMERIEUX SA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com